Matches in SemOpenAlex for { <https://semopenalex.org/work/W2325493929> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W2325493929 endingPage "S268" @default.
- W2325493929 startingPage "S267" @default.
- W2325493929 abstract "To assess the prevalence and correlates of antipsychotic polypharmacy (APP) across decades and regions.Electronic PubMed/Google Scholar search for studies reporting on APP, published from 1970 to 05/2009. Median rates and interquartile ranges (IQR) were calculated and compared using non-parametric tests. Demographic and clinical variables were tested as correlates of APP in bivariate and meta-regression analyses.Across 147 studies (1,418,163 participants, 82.9% diagnosed with schizophrenia [IQR = 42-100%]), the median APP rate was 19.6% (IQR = 12.9-35.0%). Most common combinations included first-generation antipsychotics (FGAs) + second-generation antipsychotics (SGAs) (42.4%, IQR = 0.0–71.4%) followed by FGAs + FGAs (19.6%, IQR = 0.0–100%) and SGAs + SGAs (1.8%, IQR = 0.0–28%). APP rates were not different between decades (1970–1979:28.8%, IQR = 7.5–44%; 1980–1989:17.6%, IQR = 10.8–38.2; 1990–1999:22.0%, IQR = 11–40; 2000–2009:19.2% IQR = 14.4–29.9, p = 0.78), but between regions, being higher in Asia and Europe than North America, and in Asia than Oceania (p < 0.001). APP increased numerically by 34% in North America from the 1980s 12.7%) to 2000s (17.0%) (p = 0.94) and decreased significantly by 65% from 1980 (55.5%) to 2000 (19.2%) in Asia (p = 0.03), with non-significant changes in Europe. APP was associated with inpatient status (p < 0.001), use of FGAs (p < 0.0001) and anticholinergics (< 0.001), schizophrenia (p = 0.01), less antidepressant use (p = 0.02), greater LAIs use (p = 0.04), shorter follow-up (p = 0.001) and cross-sectional vs. longitudinal study design (p = 0.03). In a meta-regression, inpatient status (p < 0.0001), FGA use (0.046), and schizophrenia diagnosis (p = 0.004) independently predicted APP (N = 66, R2 = 0.44, p < 0.0001).APP is common with different rates and time trends by region over the last four decades. APP is associated with greater anticholinergic requirement, shorter observation time, greater illness severity and lower antidepressant use." @default.
- W2325493929 created "2016-06-24" @default.
- W2325493929 creator A5003316066 @default.
- W2325493929 creator A5014286457 @default.
- W2325493929 creator A5019391929 @default.
- W2325493929 creator A5019697764 @default.
- W2325493929 creator A5026364475 @default.
- W2325493929 creator A5039005518 @default.
- W2325493929 creator A5041204037 @default.
- W2325493929 creator A5045508438 @default.
- W2325493929 date "2012-04-01" @default.
- W2325493929 modified "2023-10-13" @default.
- W2325493929 title "Poster #227 LOCUS OF CONTROL AND SELF-ESTEEM IN PATIENTS AT THEIR FIRST PSYCHOTIC EPISODE" @default.
- W2325493929 doi "https://doi.org/10.1016/s0920-9964(12)70798-3" @default.
- W2325493929 hasPublicationYear "2012" @default.
- W2325493929 type Work @default.
- W2325493929 sameAs 2325493929 @default.
- W2325493929 citedByCount "0" @default.
- W2325493929 crossrefType "journal-article" @default.
- W2325493929 hasAuthorship W2325493929A5003316066 @default.
- W2325493929 hasAuthorship W2325493929A5014286457 @default.
- W2325493929 hasAuthorship W2325493929A5019391929 @default.
- W2325493929 hasAuthorship W2325493929A5019697764 @default.
- W2325493929 hasAuthorship W2325493929A5026364475 @default.
- W2325493929 hasAuthorship W2325493929A5039005518 @default.
- W2325493929 hasAuthorship W2325493929A5041204037 @default.
- W2325493929 hasAuthorship W2325493929A5045508438 @default.
- W2325493929 hasConcept C118552586 @default.
- W2325493929 hasConcept C119060515 @default.
- W2325493929 hasConcept C126322002 @default.
- W2325493929 hasConcept C144024400 @default.
- W2325493929 hasConcept C149923435 @default.
- W2325493929 hasConcept C2776412080 @default.
- W2325493929 hasConcept C36434225 @default.
- W2325493929 hasConcept C71924100 @default.
- W2325493929 hasConceptScore W2325493929C118552586 @default.
- W2325493929 hasConceptScore W2325493929C119060515 @default.
- W2325493929 hasConceptScore W2325493929C126322002 @default.
- W2325493929 hasConceptScore W2325493929C144024400 @default.
- W2325493929 hasConceptScore W2325493929C149923435 @default.
- W2325493929 hasConceptScore W2325493929C2776412080 @default.
- W2325493929 hasConceptScore W2325493929C36434225 @default.
- W2325493929 hasConceptScore W2325493929C71924100 @default.
- W2325493929 hasLocation W23254939291 @default.
- W2325493929 hasOpenAccess W2325493929 @default.
- W2325493929 hasPrimaryLocation W23254939291 @default.
- W2325493929 hasRelatedWork W2061253854 @default.
- W2325493929 hasRelatedWork W2135585866 @default.
- W2325493929 hasRelatedWork W2157276427 @default.
- W2325493929 hasRelatedWork W2186921438 @default.
- W2325493929 hasRelatedWork W2735801383 @default.
- W2325493929 hasRelatedWork W2796274098 @default.
- W2325493929 hasRelatedWork W2971392718 @default.
- W2325493929 hasRelatedWork W3162511055 @default.
- W2325493929 hasRelatedWork W3185888555 @default.
- W2325493929 hasRelatedWork W4241099082 @default.
- W2325493929 hasVolume "136" @default.
- W2325493929 isParatext "false" @default.
- W2325493929 isRetracted "false" @default.
- W2325493929 magId "2325493929" @default.
- W2325493929 workType "article" @default.